Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients
Clinical trial NCT00273871 · COMPLETED
Trial details
- NCT number
- NCT00273871
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.